• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

DOXORUBICIN

p53 and Autophagy Drugs

August 24, 2018Autophagy, Cancer, Vizit Graphs
p53 and Autophagy Drugs

Explore p53 Pathways and Autophagy related drugs with Vizit. Explore the live graph.

Breast Cancer and CDK4/6

August 24, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Breast Cancer and CDK4/6

Drugs related to Breast Cancer and CDK4/6 gene. Explore the live graph.

Vizit Graphs Tag Cloud

TP53 AGING STAPHYLOCOCCUS AUREUS APOPTOTIC PROCESS CTLA4 CD4 IFNG ALZHEIMER'S DISEASE CELL PROLIFERATION FOXP3 IMMUNE RESPONSE CANCER ERBB-2 PARKINSON DISEASE CELL DIVISION RECEPTOR 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CASP3 CELL DIFFERENTIATION INSULIN STREPTOCOCCUS PNEUMONIAE IL17A CELL DEATH INFLAMMATION ESCHERICHIA COLI RHEUMATOID ARTHRITIS REMICADE ANGIOGENESIS LISTERIA MONOCYTOGENES TNF PORPHYROMONAS GINGIVALIS AUTOPHAGY NEURODEGENERATIVE DISORDERS PSEUDOMONAS AERUGINOSA DIABETES MELLITUS HELICOBACTER PYLORI CANDIDA ALBICANS IL6 DOXORUBICIN METFORMIN CLOSTRIDIUM DIFFICILE TH17 CELLS SOD1 BREAST CANCER IL23A

© 2019 Biovista Vizit All Rights Reserved.